Silo Pharma, Inc. (SILO) News
Follow Silo Pharma, Inc. (SILO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Silo Pharma Acquires Software and IP Assets for 150,000 Shares
Silo Pharma entered an asset purchase agreement to acquire software and related intellectual property from Larry King, issuing 150,000 common shares as consideration. The shares are subject to a lock-up of up to 12 month
EQUITY | Oct 14, 2026, 08:33 PM UTC
M
Silo Pharma Acquires Software and IP From Norsight; Issues Warrant
Silo Pharma entered into an asset purchase agreement to acquire software, technology, and related intellectual property from Norsight. As consideration, the company issued a warrant to purchase up to 300,000 shares at $1
EQUITY | Oct 02, 2026, 08:43 PM UTC
L
SILO - Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
SILO - Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
NEWS | Sep 18, 2026, 12:50 PM UTC
L
SILO - Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
SILO - Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
EQUITY | Sep 09, 2026, 01:15 PM UTC
L
Silo Pharma gets notice of allowance for Canadian PTSD patent application
Silo Pharma (SILO) received a notice of allowance for a Canadian patent application covering a novel PTSD treatment, per the TradeXchange Newsdesk alert.
REGULATION | Aug 18, 2026, 08:15 PM UTC
M
Silo Pharma Subsidiary Collaborates with Caylent
Silo Pharma subsidiary partners with Caylent
EQUITY | Aug 06, 2026, 12:50 PM UTC
L
SILO Silo Pharma files to sell 1.91M shares of common stock for holders
SILO Silo Pharma files to sell 1.91M shares of common stock for holders
EQUITY | Jul 24, 2026, 08:07 PM UTC
L
SILO AMD Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform Access to AMD Developer Cloud credi
SILO AMD Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform Access to AMD Developer Cloud credits, AI development Tools and technical resources to support next-generation ente
EQUITY | Jul 14, 2026, 12:58 PM UTC
M
SILO: Reports Positive Data
Silo Pharma reports positive stability data for SPC-15 PTSD treatment, advancing program toward first-in-human clinical trial
EARNINGS | Jun 23, 2026, 12:23 PM UTC